- Home
- OLMA vs NFJ Comparison
OLMA vs NFJ Comparison
Compare OLMA & NFJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OLMA | NFJ |
|---|---|---|
| Founded | 2006 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | OLMA | NFJ |
|---|---|---|
| Price | $15.27 | $14.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $44.89 | N/A |
| AVG Volume (30 Days) | ★ 841.7K | 224.2K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.01% |
| EPS Growth | ★ 15.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.89 | $11.42 |
| 52 Week High | $36.26 | $14.17 |
Technical Indicators
Market Signals| Indicator | OLMA | NFJ |
|---|---|---|
| Relative Strength Index (RSI) | 40.24 | 71.05 |
| Support Level | $13.11 | $12.73 |
| Resistance Level | $16.99 | N/A |
| Average True Range (ATR) | 0.84 | 0.18 |
| MACD | 0.17 | 0.09 |
| Stochastic Oscillator | 16.50 | 93.25 |
Price Performance
Historical ComparisonAbout OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. The primary investment objective of the company is to seek current income and gains, with a secondary objective of long-term capital appreciation. It pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.